Pharmaceutical giant pleads guilty to three criminal charges over mis-selling of drugs and withholding of dataGlaxoSmithKline has agreed to plead guilty to misdemeanour criminal charges and pay $3bn to settle what government officials described as the largest case of healthcare fraud in US history.The agreement, which still needs court approval, would resolve allegations that the British drug maker broke US laws in the marketing and development of pharmaceuticals. The terms of the settlement were announced in November.GSK targeted the antidepressant Paxil at patients under age 18 when it was approved for adults only, and it promoted the drug Wellbutrin for uses it was not approved for, including weight loss and treatment of sexual dysfunction, according to an investigation led by the US Justice Department.The company went to extreme lengths to promote the drugs, such as distributing a misleading medical journal article and providing doctors with meals and spa treatments that...
- ICT fails to accelerate drug approvalsThu, 19 Nov 2009, 9:58:09 EST
- Off-label marketing of medicines in the US is rife but difficult to controlTue, 5 Apr 2011, 18:33:26 EDT
- Researchers: Strengthen restrictions on off-label promotion by pharmaceutical companiesTue, 28 Oct 2008, 1:43:02 EDT
- FDA considers new rules to speed up confirmatory trials of drugs granted accelerated approvalFri, 25 Mar 2011, 17:33:23 EDT
- Physician calls for more rigorous standards for drugs up for FDA approvalTue, 9 Mar 2010, 17:35:33 EST